Global Contraceptive Drugs And Devices Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the contraceptive drugs and devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Contraceptive Drugs And Devices Market In The Period 2029-2034?

The market for contraceptive drugs and devices has experienced significant expansion recently. Projections indicate its size will increase from $25.3 billion in 2024 to reach $26.98 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as demographic increase, heightened public knowledge of family planning, governmental support and financial backing, a growing female workforce, and innovations in contraceptive methods.

The contraceptive drugs and devices market is projected to experience substantial expansion in the coming years. This market is predicted to reach $35.55 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this anticipated growth include an increasing demand for long-acting reversible contraceptives, a heightened emphasis on women’s reproductive health, the rising occurrence of sexually transmitted infections, broader accessibility via e-commerce and telehealth platforms, along with favorable healthcare policies and comprehensive insurance coverage. Key trends expected during this period encompass smart contraceptive devices featuring digital tracking capabilities, biodegradable implants and patches, breakthroughs in hormone-free contraception, artificial intelligence-powered fertility monitoring applications, and the use of 3D printing for personalized contraceptive devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp

What Strategic Drivers Are Accelerating The Contraceptive Drugs And Devices Market Expansion?

An increasing number of government programs focused on reproductive health is projected to drive the expansion of the contraceptive drugs and devices market moving ahead. These governmental efforts advance reproductive well-being by raising awareness, providing financial support, and ensuring availability of services. The expansion of government programs concerning reproductive health stems from a growing acknowledgment of the necessity to tackle matters like maternal health, family planning, and access to vital healthcare provisions, all of which are fundamental for comprehensive societal prosperity and progress. Specific government endeavors for contraceptive drugs and devices seek to enhance the availability of economical and efficient family planning options, thereby enabling individuals to make educated decisions regarding their reproductive health. As an illustration, in November 2024, as reported by the Australian Government Department of Foreign Affairs and Trade, an Australia-based governmental body, Australia plans to commit $56.8 million towards a new project designed to advance sexual and reproductive health and rights across Southeast Asia. Consequently, the growing volume of government initiatives regarding reproductive health is fueling the growth of the contraceptive drugs and devices market.

What Is The Detailed Segment Distribution Of The Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market covered in this report is segmented –

1) By Product: Contraceptive Drugs, Contraceptive Devices

2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels

4) By End User: Male, Female

Subsegments:

1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants

2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

How Are Global Trends Impacting The Development Of The Contraceptive Drugs And Devices Market?

Leading companies active in the contraceptive drugs and devices market are innovating products like contraceptive vaginal rings to improve user convenience and increase long-acting contraceptive alternatives. A contraceptive vaginal ring is a pliable, hormone-emitting device positioned in the vagina to prevent pregnancy through the suppression of ovulation. For example, in October 2023, Xiromed LLC, a US-based pharmaceutical firm, introduced EnilloRing, a gentle, flexible contraceptive vaginal ring crafted for vaginal insertion. It continuously releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to inhibit ovulation. As a bioequivalent generic to NuvaRing, it provides women with a convenient, private, and budget-friendly monthly birth control solution that eliminates daily dosing while retaining the same safety, efficacy, and tolerability profile as the branded version.

Who Are The Major Stakeholders Operating In The Contraceptive Drugs And Devices Market?

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/contraceptive-drugs-and-devices-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Contraceptive Drugs And Devices Market?

North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp

Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2025, By The Business Research Company

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795